Nösslinger T - Search Results

1

Multistep pathogenesis of chronic myelomonocytic leukemia in patients.

Geissler K, Jäger E, Barna A, Gurbisz M, Marschon R, Graf T, Nösslinger T, Pfeilstöcker M, Machherndl-Spandl S, Stauder R, Zebisch A, Sill H, Öhler L, Kusec R, Hoermann G, Valent P. Geissler K, et al. Among authors: nosslinger t. Eur J Haematol. 2022 Jul;109(1):50-57. doi: 10.1111/ejh.13768. Epub 2022 Mar 23. Eur J Haematol. 2022. PMID: 35299281 Free PMC article.

2

Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics.

Pfeilstöcker M, Reisner R, Nösslinger T, Grüner H, Nowotny H, Tüchler H, Schlögl E, Pittermann E, Heinz R. Pfeilstöcker M, et al. Among authors: nosslinger t. Br J Haematol. 1999 Aug;106(2):455-63. doi: 10.1046/j.1365-2141.1999.01559.x. Br J Haematol. 1999. PMID: 10460606 Free article.

3

Dysplastic versus proliferative CMML--a retrospective analysis of 91 patients from a single institution.

Nösslinger T, Reisner R, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M. Nösslinger T, et al. Leuk Res. 2001 Sep;25(9):741-7. doi: 10.1016/s0145-2126(01)00014-5. Leuk Res. 2001. PMID: 11489467

4

Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution.

Nösslinger T, Reisner R, Koller E, Grüner H, Tüchler H, Nowotny H, Pittermann E, Pfeilstöcker M. Nösslinger T, et al. Blood. 2001 Nov 15;98(10):2935-41. doi: 10.1182/blood.v98.10.2935. Blood. 2001. PMID: 11698274 Free article.

5

Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Galpha16 and 5'-lipoxygenase.

Pfeilstöcker M, Karlic H, Nösslinger T, Tüchler H, Lohninger A, Pittermann E. Pfeilstöcker M, et al. Among authors: nosslinger t. Ann Hematol. 2002 Nov;81(11):632-40. doi: 10.1007/s00277-002-0536-6. Epub 2002 Oct 23. Ann Hematol. 2002. PMID: 12454701

6

Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.

Kaufmann H, Krömer E, Nösslinger T, Weltermann A, Ackermann J, Reisner R, Bernhart M, Drach J. Kaufmann H, et al. Among authors: nosslinger t. Eur J Haematol. 2003 Sep;71(3):179-83. doi: 10.1034/j.1600-0609.2003.00111.x. Eur J Haematol. 2003. PMID: 12930318

7

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS).

Germing U, Hildebrandt B, Pfeilstöcker M, Nösslinger T, Valent P, Fonatsch C, Lübbert M, Haase D, Steidl C, Krieger O, Stauder R, Giagounidis AA, Strupp C, Kündgen A, Mueller T, Haas R, Gattermann N, Aul C. Germing U, et al. Among authors: nosslinger t. Leukemia. 2005 Dec;19(12):2223-31. doi: 10.1038/sj.leu.2403963. Leukemia. 2005. PMID: 16193087

8

Chromosomal abnormalities of young multiple myeloma patients (<45 yr) are not different from those of other age groups and are independent of stage according to the International Staging System.

Sagaster V, Kaufmann H, Odelga V, Ackermann J, Gisslinger H, Rabitsch W, Zojer N, Ludwig H, Nösslinger T, Zielinski C, Drach J. Sagaster V, et al. Among authors: nosslinger t. Eur J Haematol. 2007 Mar;78(3):227-34. doi: 10.1111/j.1600-0609.2006.00807.x. Epub 2007 Jan 23. Eur J Haematol. 2007. PMID: 17253972

9

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients.

Haase D, Germing U, Schanz J, Pfeilstöcker M, Nösslinger T, Hildebrandt B, Kundgen A, Lübbert M, Kunzmann R, Giagounidis AA, Aul C, Trümper L, Krieger O, Stauder R, Müller TH, Wimazal F, Valent P, Fonatsch C, Steidl C. Haase D, et al. Among authors: nosslinger t. Blood. 2007 Dec 15;110(13):4385-95. doi: 10.1182/blood-2007-03-082404. Epub 2007 Aug 28. Blood. 2007. PMID: 17726160 Free article.

10

Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implications.

Pfeilstöcker M, Karlic H, Nösslinger T, Sperr W, Stauder R, Krieger O, Valent P. Pfeilstöcker M, et al. Among authors: nosslinger t. Leuk Lymphoma. 2007 Oct;48(10):1900-9. doi: 10.1080/10428190701534382. Leuk Lymphoma. 2007. PMID: 17917959 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

53 results

Search Page